Effect of sulfonylurea agents on reverse cholesterol transport in vitro and vivo

Journal of Atherosclerosis and Thrombosis

Volumn 18, Issue 6, 2011, Pages 513-530

  Terao, Yoshio ^a,b   Ayaori, Makoto ^a   Ogura, Masatsune ^a   Yakushiji, Emi ^a   Uto Kondo, Harumi ^a   Hisada, Tetsuya ^a   Ozasa, Hideki ^a,b   Takiguchi, Shunichi ^a   Nakaya, Kazuhiro ^a   Sasaki, Makoto ^a   Komatsu, Tomohiro ^a   Iizuka, Maki ^a   Horii, Shunpei ^a   Mochizuki, Seibu ^c   Yoshimura, Michihiro ^b   Ikewaki, Katsunori ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^b JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c MUSASHINO UNIVERSITY   (Japan)

Author keywords

Cholesterol efflux; Macrophage; RCT; Sulfonylurea

Indexed keywords

ABC TRANSPORTER A1; ABC TRANSPORTER G1; ACETYL LOW DENSITY LIPOPROTEIN; APOLIPOPROTEIN A1; GLIBENCLAMIDE; GLIMEPIRIDE; HIGH DENSITY LIPOPROTEIN; SCAVENGER RECEPTOR BI;

ANIMAL CELL; ARTICLE; CHOLESTEROL TRANSPORT; DRUG EFFECT; DRUG INHIBITION; IN VITRO STUDY; IN VIVO STUDY; MACROPHAGE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REVERSE CHOLESTEROL TRANSPORT;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; BIOLOGICAL TRANSPORT; BLOTTING, WESTERN; CELLS, CULTURED; CHOLESTEROL; CRICETINAE; GLYBURIDE; HEK293 CELLS; HUMANS; HYPOGLYCEMIC AGENTS; LIVER; MACROPHAGES; MACROPHAGES, PERITONEAL; MALE; MICE; MICE, INBRED C57BL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SCAVENGER RECEPTORS, CLASS B;

EID: 79959817628     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.7641     Document Type: Article

References (47)

1. Lewis GF, Rader DJ: New insights into the regulation of HDL metabolism and reverse cholesterol transport. Circ Res, 2005; 96: 1221-1232
2. Wang N, Silver DL, Thiele C, Tall AR: ATP-binding cas- sette transporter A1 (ABCA1) functions as a cholesterol efflux regulatory protein. J Biol Chem, 2001; 276: 23742-23747
3. Yokoyama S: ABCA1 and biogenesis of HDL. J Athero- scler Thromb, 2006; 13: 1-15
4. Wang N, Lan D, Chen W, Matsuura F, Tall AR: ATP- binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins. Proc Natl Acad Sci U S A, 2004; 101: 9774-9779
5. Ohgami N, Miyazaki A, Sakai M, Kuniyasu A, Nakayama H, Horiuchi S: Advanced glycation end products (AGE) inhibit scavenger receptor class B type I-mediated reverse cholesterol transport: a new crossroad of AGE to choles- terol metabolism. J Atheroscler Thromb, 2003; 10: 1-6
6. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M: Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med, 1998; 339: 229-234
7. Sarwar N, Gao P, Seshasai SR, Gobin R, Kaptoge S, Di Angelantonio E, Ingelsson E, Lawlor DA, Selvin E, Stampfer M, Stehouwer CD, Lewington S, Pennells L, Thompson A, Sattar N, White IR, Ray KK, Danesh J: Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet, 2010; 375: 2215-2222
8. Oyama T, Saiki A, Endoh K, Ban N, Nagayama D, Ohhi- ra M, Koide N, Miyashita Y, Shirai K: Effect of acarbose, an alpha-glucosidase inhibitor, on serum lipoprotein li- pase mass levels and common carotid artery intima-media thickness in type 2 diabetes mellitus treated by sulfonyl- urea. J Atheroscler Thromb, 2008; 15: 154-159
9. Kar P, Holt RI: The effect of sulphonylureas on the mi- crovascular and macrovascular complications of diabetes. Cardiovasc Drugs Ther, 2008; 22: 207-213
10. Fielding PE, Nagao K, Hakamata H, Chimini G, Fielding CJ: A two-step mechanism for free cholesterol and phos- pholipid efflux from human vascular cells to apolipopro- tein A-1. Biochemistry, 2000; 39: 14113-14120
11. Feng B, Tabas I: ABCA1-mediated cholesterol efflux is de- fective in free cholesterol-loaded macrophages. Mechanism involves enhanced ABCA1 degradation in a process requiring full NPC1 activity. J Biol Chem, 2002; 277: 43271-43280
12. Burgess JW, Kiss RS, Zheng H, Zachariah S, Marcel YL: Trypsin-sensitive and lipid-containing sites of the macro- phage extracellular matrix bind apolipoprotein A-I and participate in ABCA1-dependent cholesterol efflux. J Biol Chem, 2002; 277: 31318-31326
13. Marguet D, Luciani MF, Moynault A, Williamson P, Chi- mini G: Engulfment of apoptotic cells involves the redis- tribution of membrane phosphatidylserine on phagocyte and prey. Nat Cell Biol, 1999; 1: 454-456
14. Nieland TJ, Chroni A, Fitzgerald ML, Maliga Z, Zannis VI, Kirchhausen T, Krieger M: Cross-inhibition of SR-BI- and ABCA1-mediated cholesterol transport by the small molecules BLT-4 and glyburide. J Lipid Res, 2004; 45: 1256-1265
15. Ayaori M, Sawada S, Yonemura A, Iwamoto N, Ogura M, Tanaka N, Nakaya K, Kusuhara M, Nakamura H, Ohsu- zu F: Glucocorticoid receptor regulates ATP-binding cassette transporter-A1 expression and apolipoprotein-medi- ated cholesterol efflux from macrophages. Arterioscler Thromb Vasc Biol, 2006; 26: 163-168
16. Nakaya K, Ayaori M, Hisada T, Sawada S, Tanaka N, Iwa- moto N, Ogura M, Yakushiji E, Kusuhara M, Nakamura H, Ohsuzu F: Telmisartan enhances cholesterol efflux from THP-1 macrophages by activating PPARgamma. J Atheroscler Thromb, 2007; 14: 133-141
17. Hajj Hassan H, Blain S, Boucher B, Denis M, Krimbou L, Genest J: Structural modification of plasma HDL by phospholipids promotes efficient ABCA1-mediated cho- lesterol release. J Lipid Res, 2005; 46: 1457-1465
18. Iwamoto N, Abe-Dohmae S, Ayaori M, Tanaka N, Kusu- hara M, Ohsuzu F, Yokoyama S: ATP-binding cassette transporter A1 gene transcription is downregulated by ac- tivator protein 2alpha. Doxazosin inhibits activator pro- tein 2alpha and increases high-density lipoprotein biogen- esis independent of alpha1-adrenoceptor blockade. Circ Res, 2007; 101: 156-165
19. Dugi KA, Amar MJ, Haudenschild CC, Shamburek RD, Bensadoun A, Hoyt RF, Jr., Fruchart-Najib J, Madj Z, Brewer HB, Jr., Santamarina-Fojo S: In vivo evidence for both lipolytic and nonlipolytic function of hepatic lipase in the metabolism of HDL. Arterioscler Thromb Vasc Biol, 2000; 20: 793-800
20. Vogelstein B, Lane D, Levine AJ: Surfing the p53 network. Nature, 2000; 408: 307-310
21. Tanigawa H, Billheimer JT, Tohyama J, Zhang Y, Rothblat G, Rader DJ: Expression of cholesteryl ester transfer protein in mice promotes macrophage reverse cholesterol transport. Circulation, 2007; 116: 1267-1273
22. Uto-Kondo H, Ayaori M, Ogura M, Nakaya K, Ito M, Suzuki A, Takiguchi S, Yakushiji E, Terao Y, Ozasa H, Hisada T, Sasaki M, Ohsuzu F, Ikewaki K: Coffee con- sumption enhances high-density lipoprotein-mediated cholesterol efflux in macrophages. Circ Res, 2010; 106: 779-787
23. Nakaya K, Ayaori M, Uto-Kondo H, Hisada T, Ogura M, Yakushiji E, Takiguchi S, Terao Y, Ozasa H, Sasaki M, Komatsu T, Ohsuzu F, Ikewaki K: Cilostazol enhances macrophage reverse cholesterol transport in vitro and in vivo. Atherosclerosis, 2010; 213: 135-141
24. Bryan J, Aguilar-Bryan L: Sulfonylurea receptors: ABC transporters that regulate ATP-sensitive K(+) channels. Biochim Biophys Acta, 1999; 1461: 285-303
25. Sheppard DN, Welsh MJ: Effect of ATP-sensitive K+ channel regulators on cystic fibrosis transmembrane con- ductance regulator chloride currents. J Gen Physiol, 1992; 100: 573-591
26. Golstein PE, Boom A, van Geffel J, Jacobs P, Masereel B, Beauwens R: P-glycoprotein inhibition by glibenclamide and related compounds. Pflugers Arch, 1999; 437: 652-660
27. Kis E, Ioja E, Nagy T, Szente L, Heredi-Szabo K, Krajcsi P: Effect of membrane cholesterol on BSEP/Bsep activity: species specificity studies for substrates and inhibitors. Drug Metab Dispos, 2009; 37: 1878-1886
28. Sheppard DN, Robinson KA: Mechanism of glibenclamide inhibition of cystic fibrosis transmembrane con- ductance regulator Cl- channels expressed in a murine cell line. J Physiol, 1997; 503 (Pt 2): 333-346
29. Fitzgerald ML, Morris AL, Chroni A, Mendez AJ, Zannis VI, Freeman MW: ABCA1 and amphipathic apolipoproteins form high-affinity molecular complexes required for cholesterol efflux. J Lipid Res, 2004; 45: 287-294
30. Kobayashi A, Takanezawa Y, Hirata T, Shimizu Y, Misasa K, Kioka N, Arai H, Ueda K, Matsuo M: Efflux of sphin- gomyelin, cholesterol, and phosphatidylcholine by ABCG1. J Lipid Res, 2006; 47: 1791-1802
31. Wittenburg H, Carey MC: Biliary cholesterol secretion by the twinned sterol half-transporters ABCG5 and ABCG8. J Clin Invest, 2002; 110: 605-609
32. Ohgami N, Kuniyasu A, Furukawa K, Miyazaki A, Haka- mata H, Horiuchi S, Nakayama H: Glibenclamide acts as an inhibitor of acyl-CoA:cholesterol acyltransferase en- zyme. Biochem Biophys Res Commun, 2000; 277: 417-422
33. Hakamata H, Miyazaki A, Sakai M, Suginohara Y, Saka- moto Y, Horiuchi S: Species difference in cholesteryl ester cycle and HDL-induced cholesterol efflux from macro- phage foam cells. Arterioscler Thromb, 1994; 14: 1860-1865
34. Bernard DW, Rodriguez A, Rothblat GH, Glick JM: In- fluence of high density lipoprotein on esterified cholester- ol stores in macrophages and hepatoma cells. Arterioscle- rosis, 1990; 10: 135-144
35. Wu CA, Tsujita M, Hayashi M, Yokoyama S: Probucol inactivates ABCA1 in the plasma membrane with respect to its mediation of apolipoprotein binding and high den- sity lipoprotein assembly and to its proteolytic degrada- tion. J Biol Chem, 2004; 279: 30168-30174
36. Hirano K, Ikegami C, Tsujii K, Zhang Z, Matsuura F, Nakagawa-Toyama Y, Koseki M, Masuda D, Maruyama T, Shimomura I, Ueda Y, Yamashita S: Probucol enhances the expression of human hepatic scavenger receptor class B type I, possibly through a species-specific mechanism. Arterioscler Thromb Vasc Biol, 2005; 25: 2422-2427
37. Nofer JR, Remaley AT, Feuerborn R, Wolinnska I, Engel T, von Eckardstein A, Assmann G: Apolipoprotein A-I acti- vates Cdc42 signaling through the ABCA1 transporter. J Lipid Res, 2006; 47: 794-803
38. Remedi MS, Nichols CG: Chronic antidiabetic sulfonyl- ureas in vivo: reversible effects on mouse pancreatic beta- cells. PLoS Med, 2008; 5: e206.
39. Wang X, Collins HL, Ranalletta M, Fuki IV, Billheimer JT, Rothblat GH, Tall AR, Rader DJ: Macrophage ABCA1 and ABCG1, but not SR-BI, promote macro- phage reverse cholesterol transport in vivo. J Clin Invest, 2007; 117: 2216-2224
40. Zhang Y, Da Silva JR, Reilly M, Billheimer JT, Rothblat GH, and Rader DJ: Hepatic expression of scavenger re- ceptor class B type I (SR-BI) is a positive regulator of macrophage reverse cholesterol transport in vivo. J Clin Invest, 2005; 115: 2870-2874
41. Uehara Y, Miura S, von Eckardstein A, Abe S, Fujii A, Matsuo Y, Rust S, Lorkowski S, Assmann G, Yamada T, Saku K: Unsaturated fatty acids suppress the expression of the ATP-binding cassette transporter G1 (ABCG1) and ABCA1 genes via an LXR/RXR responsive element. Ath- erosclerosis, 2007; 191: 11-21
42. Ayaori M, Sawada S, Yonemura A, Iwamoto N, Ogura M, Tanaka N, Nakaya K, Kusuhara M, Nakamura H, Ohsu- zu F: Glucocorticoid receptor regulates ATP-binding cas- sette transporter-A1 expression and apolipoprotein-medi- ated cholesterol efflux from macrophages. Arterioscler Thromb Vasc Biol, 2006; 26: 163-168
43. Nakaya K, Ayaori M, Hisada T, Sawada S, Tanaka N, Iwa- moto N, Ogura M, Yakushiji E, Kusuhara M, Nakamura H, Ohsuzu F: Telmisartan enhances cholesterol efflux from THP-1 macrophages by activating PPARgamma. J Atheroscler Thromb, 2007; 14: 133-141
44. Sabol SL, Brewer HB, Jr., Santamarina-Fojo S: The hu- man ABCG1 gene: identification of LXR response ele- ments that modulate expression in macrophages and liver. J Lipid Res, 2005; 46: 2151-2167
45. Stokke KT, Norum KR: Determination of lecithin: cho- lesterol acyltransfer in human blood plasma. Scand J Clin Lab Invest, 1971; 27: 21-27
46. Zhao Y, Thorngate FE, Weisgraber KH, Williams DL, Parks JS: Apolipoprotein E is the major physiological acti- vator of lecithin-cholesterol acyltransferase (LCAT) on apolipoprotein B lipoproteins. Biochemistry, 2005; 44: 1013-1025
47. Tanigawa H, Billheimer JT, Tohyama J, Fuki IV, Ng DS, Rothblat GH, Rader DJ: Lecithin: cholesterol acyltrans- ferase expression has minimal effects on macrophage re- verse cholesterol transport in vivo. Circulation, 2009; 120: 160-169